a public good project by the
Synthesis
Company
of California

© 2026

Susan Chi | doi.page

0 works0 citations0 h-index

Susan Chi

Dana-Farber/Boston Children's Cancer and Blood Disorders Center(US)

Publications by Year

Research Areas

Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Chromatin Remodeling and Cancer, Brain Metastases and Treatment, Cancer Mechanisms and Therapy

Most-Cited Works

→ Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor(2008)452 cited
→ Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma(2011)321 cited
→ Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database(2014)312 cited
→ Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies(2016)226 cited
→ A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer(2005)202 cited
→ Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study(2010)194 cited

→ A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors(2017)184 cited

→ Feasibility and Response to Induction Chemotherapy Intensified With High-Dose Methotrexate for Young Children With Newly Diagnosed High-Risk Disseminated Medulloblastoma(2004)174 cited

→ The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial(2023)159 cited

→ A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer(2013)152 cited